| Authors: |
Refsgaard L; Department of Experimental Clinical Oncology, Aarhus University Hospital, Denmark; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark. Electronic address: lasref@rm.dk., Holm Milo ML; Department of Oncology, Aalborg University Hospital, Aalborg, Denmark; Department of Clinical Medicine, Faculty of Medicine, Aalborg University, Aalborg, Denmark., Buhl ES; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark; Danish Center for Particle Therapy, Aarhus University Hospital, Aarhus, Denmark., Jensen JM; Department of Cardiology, Aarhus University Hospital, Aarhus, Denmark., Maae E; Department of Oncology, Vejle Hospital, University Hospital of Southern Denmark, Denmark., Berg M; Department of Oncology, Vejle Hospital, University Hospital of Southern Denmark, Denmark., Jensen I; Department of Oncology, Aalborg University Hospital, Aalborg, Denmark., Nielsen MH; Department of Oncology, Odense University Hospital, Odense, Denmark., Lorenzen EL; Department of Oncology, Odense University Hospital, Odense, Denmark; Department of Clinical Research, University of Southern Denmark, Odense, Denmark., Thorsen LBJ; Department of Experimental Clinical Oncology, Aarhus University Hospital, Denmark; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark., Korreman SS; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark; Danish Center for Particle Therapy, Aarhus University Hospital, Aarhus, Denmark., Offersen BV; Department of Experimental Clinical Oncology, Aarhus University Hospital, Denmark; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark; Danish Center for Particle Therapy, Aarhus University Hospital, Aarhus, Denmark. |